Chemotherapy
Neoadjuvant immunotherapy ‘the new standard’ for resectable stage III melanoma
CHICAGO — Individuals with resectable stage III melanoma derived significant EFS benefits with neoadjuvant immunotherapy compared with standard treatment, results from a randomized phase 3 trial presented at ASCO Annual Meeting showed.
Chemotherapy regimen improves survival in advanced esophageal cancer
CHIGAGO — Perioperative chemotherapy improved OS in patients with locally advanced esophageal adenocarcinoma compared with chemoradiation prior to surgery, results form a randomized phase 3 trial presented at ASCO Annual Meeting showed.
New treatment regimens improve outlook for patients with HER2-positive breast cancer
Tremendous progress has been made in the treatment landscape for HER2-positive breast cancer that has significantly altered and improved the outlook for this patient population.
Keytruda extends survival in high-risk triple negative breast cancer
A study assessing the efficacy of pembrolizumab met a key secondary endpoint of extending OS, in combination with chemotherapy, among patients with high-risk early-stage triple-negative breast cancer, according to the agent’s manufacturer.
American Transplant Congress program addresses perfusion, equity and organ procurement
Editor’s note: Healio | Nephrology News & Issues interviewed John Friedewald, MD, and Roberto Hernandez-Alejandro, MD, about their roles as conference chairpersons and highlights of the agenda for the American Transplant Congress.
Chemotherapy within 1 year after TJA may increase risk of PJI
Postoperative chemotherapy may be associated with increased risk of periprosthetic joint infection after total joint arthroplasty, according to published results.
Immune-related toxicity from immune checkpoint inhibitors linked to longer survival
Certain individuals with non-cell lung cancer who experienced immune-related adverse events due to immune checkpoint inhibitor therapy had improved survival outcomes, according to retrospective study data published in JAMA Network Open.
Findings highlight ‘desperate need’ to improve end-of-life cancer treatment
Oncologic treatment of adults with various metastatic or advanced solid tumors may not improve OS and could be detrimental to quality of life, according to findings published in JAMA Oncology.
Exercise program may improve heart function among cancer survivors
Moderate to vigorous aerobic and resistance exercise may improve vascular function among cancer survivors, according to findings presented at American Association for Cancer Research Annual Meeting.
Trial to assess novel surgical procedure for locally advanced pancreatic cancer
A clinical trial at Keck Medicine of USC will investigate a new surgical approach to treating patients with locally advanced pancreatic cancer.